HK1095587A1 - Thienopyrazoles - Google Patents

Thienopyrazoles

Info

Publication number
HK1095587A1
HK1095587A1 HK07100592A HK07100592A HK1095587A1 HK 1095587 A1 HK1095587 A1 HK 1095587A1 HK 07100592 A HK07100592 A HK 07100592A HK 07100592 A HK07100592 A HK 07100592A HK 1095587 A1 HK1095587 A1 HK 1095587A1
Authority
HK
Hong Kong
Prior art keywords
thienopyrazoles
itk
inhibition
modulated
compounds
Prior art date
Application number
HK07100592A
Other languages
English (en)
Inventor
Jurcak John Gerard
Barrague Matthieu
Gillespy Timothy Alan
Edwards Michael Louis
Musick Kwon Yon
Weintraub Philip Marvin
Du Yan
Ramalinga M Dharanipragada
Parkar Ashfaq Ahmed
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of HK1095587A1 publication Critical patent/HK1095587A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
HK07100592A 2003-09-08 2007-01-17 Thienopyrazoles HK1095587A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50115903P 2003-09-08 2003-09-08
PCT/US2004/023814 WO2005026175A1 (en) 2003-09-08 2004-07-23 Thienopyrazoles

Publications (1)

Publication Number Publication Date
HK1095587A1 true HK1095587A1 (en) 2007-05-11

Family

ID=34312256

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07100592A HK1095587A1 (en) 2003-09-08 2007-01-17 Thienopyrazoles

Country Status (30)

Country Link
US (2) US7518000B2 (pt)
JP (1) JP4879739B2 (pt)
KR (1) KR20060069490A (pt)
CN (1) CN100398545C (pt)
AT (1) ATE468341T1 (pt)
AU (1) AU2004272507B2 (pt)
BR (1) BRPI0414215A (pt)
CA (1) CA2538032C (pt)
CR (1) CR8255A (pt)
DE (1) DE602004027288D1 (pt)
DK (1) DK1682553T3 (pt)
EC (1) ECSP066411A (pt)
ES (1) ES2345257T3 (pt)
HK (1) HK1095587A1 (pt)
HR (1) HRP20100398T1 (pt)
IL (1) IL173916A (pt)
MA (1) MA28038A1 (pt)
ME (1) MEP20908A (pt)
MX (1) MXPA06001827A (pt)
MY (1) MY144339A (pt)
NO (1) NO20061626L (pt)
NZ (1) NZ545421A (pt)
OA (1) OA13252A (pt)
PT (1) PT1682553E (pt)
RS (2) RS51846B (pt)
RU (1) RU2358978C2 (pt)
TN (1) TNSN06058A1 (pt)
TW (1) TWI352705B (pt)
WO (1) WO2005026175A1 (pt)
ZA (1) ZA200601947B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006101454A1 (en) * 2005-03-21 2006-09-28 S*Bio Pte Ltd Benzothiophene derivatives: preparation and pharmaceutical applications
JP2009520831A (ja) * 2005-12-20 2009-05-28 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｔｅｃキナーゼインヒビター
EP2151433A1 (en) 2008-08-05 2010-02-10 Institut Pasteur Alkoxypyrazoles and the process for their preparation
EP2151434A1 (en) 2008-08-05 2010-02-10 Institut Pasteur Alkoxypyrazoles and the process for their preparation
US8299070B2 (en) * 2009-11-25 2012-10-30 Japan Tobacco Inc. Indole compounds and pharmaceutical use thereof
US20130158066A1 (en) * 2011-12-20 2013-06-20 Hoffmann-La Roche Inc. 4-azaindole inhibitors of crac
WO2013153539A1 (en) 2012-04-13 2013-10-17 Glenmark Pharmaceuticals S.A. Tricyclic compounds as tec kinase inhibitors
CN103467481B (zh) * 2012-06-07 2016-08-31 上海汇伦生命科技有限公司 二氢吡啶类化合物、其组合物、制备方法和用途
TW201414734A (zh) 2012-07-10 2014-04-16 Takeda Pharmaceutical 氮雜吲哚衍生物
WO2014041518A1 (en) * 2012-09-14 2014-03-20 Glenmark Pharmaceuticals S.A. Thienopyrrole derivatives as itk inhibitors
CN103720694A (zh) * 2012-10-11 2014-04-16 韩冰 一类治疗脑性瘫痪的化合物及其用途
CN103772391A (zh) * 2012-10-23 2014-05-07 杨子娇 一类治疗房角狭窄的化合物及其用途
KR101571590B1 (ko) * 2012-11-21 2015-11-25 주식회사 두산 유기 화합물 및 이를 이용하는 유기 전계 발광 소자
JP2016538270A (ja) 2013-10-25 2016-12-08 ファーマサイクリックス エルエルシー 移植片対宿主病を処置し予防する方法
AR099052A1 (es) 2014-01-09 2016-06-29 Takeda Pharmaceuticals Co Derivados de azaindol
WO2016010108A1 (ja) * 2014-07-18 2016-01-21 塩野義製薬株式会社 含窒素複素環誘導体およびそれらを含有する医薬組成物
MA45973A (fr) 2015-08-31 2019-06-26 Pharmacyclics Llc Combinaisons d'inhibiteurs de btk pour le traitement du myélome multiple
MX2019005029A (es) 2016-11-03 2019-10-24 Juno Therapeutics Inc Terapia de combinación de una terapia de células t y un inhibidor de tirosina cinasa de bruton (btk).
EP3787751A1 (en) 2018-05-03 2021-03-10 Juno Therapeutics, Inc. Combination therapy of a chimeric antigen receptor (car) t cell therapy and a kinase inhibitor
WO2023139248A1 (en) * 2022-01-21 2023-07-27 Ecole Polytechnique Federale De Lausanne (Epfl) Inhibitors of acyl protein thioesterases against microbial infections
WO2023220655A1 (en) 2022-05-11 2023-11-16 Celgene Corporation Methods to overcome drug resistance by re-sensitizing cancer cells to treatment with a prior therapy via treatment with a t cell therapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6462036B1 (en) * 1998-11-06 2002-10-08 Basf Aktiengesellschaft Tricyclic pyrazole derivatives
US6297238B1 (en) * 1999-04-06 2001-10-02 Basf Aktiengesellschaft Therapeutic agents
ATE301651T1 (de) * 1999-06-23 2005-08-15 Aventis Pharma Gmbh Substituierte benzimidazole
YU54202A (sh) * 2000-01-18 2006-01-16 Agouron Pharmaceuticals Inc. Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
US7101884B2 (en) * 2001-09-14 2006-09-05 Merck & Co., Inc. Tyrosine kinase inhibitors
JP5039268B2 (ja) * 2001-10-26 2012-10-03 アベンティス・ファーマスーティカルズ・インコーポレイテツド ベンゾイミダゾールおよび類縁体および蛋白キナーゼ阻害剤としてのその使用
FR2831536A1 (fr) * 2001-10-26 2003-05-02 Aventis Pharma Sa Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de kdr

Also Published As

Publication number Publication date
NZ545421A (en) 2010-03-26
MXPA06001827A (es) 2006-05-31
US20100056514A1 (en) 2010-03-04
DE602004027288D1 (en) 2010-07-01
MY144339A (en) 2011-08-29
DK1682553T3 (da) 2010-08-23
HRP20100398T1 (hr) 2010-09-30
CA2538032A1 (en) 2005-03-24
ZA200601947B (en) 2007-05-30
WO2005026175A1 (en) 2005-03-24
CR8255A (es) 2006-07-14
ES2345257T3 (es) 2010-09-20
US20070254937A1 (en) 2007-11-01
RU2358978C2 (ru) 2009-06-20
ECSP066411A (es) 2006-09-18
IL173916A (en) 2011-07-31
JP4879739B2 (ja) 2012-02-22
AU2004272507A1 (en) 2005-03-24
TW200519118A (en) 2005-06-16
TNSN06058A1 (en) 2007-10-03
US7928231B2 (en) 2011-04-19
IL173916A0 (en) 2006-07-05
RU2006111470A (ru) 2007-10-27
US7518000B2 (en) 2009-04-14
JP2007505038A (ja) 2007-03-08
AU2004272507B2 (en) 2011-05-12
KR20060069490A (ko) 2006-06-21
OA13252A (en) 2007-01-31
RS51846B (en) 2012-02-29
NO20061626L (no) 2006-04-10
ATE468341T1 (de) 2010-06-15
CN100398545C (zh) 2008-07-02
MEP20908A (en) 2010-06-10
MA28038A1 (fr) 2006-07-03
RS20060162A (en) 2008-06-05
TWI352705B (en) 2011-11-21
CA2538032C (en) 2011-01-11
CN1849322A (zh) 2006-10-18
PT1682553E (pt) 2010-07-29
BRPI0414215A (pt) 2006-11-07

Similar Documents

Publication Publication Date Title
IL173916A0 (en) Thienopyrazoles
IL173348A (en) Thienopyridine compounds, pharmaceuticals containing them and their use in the preparation of drugs
MXPA05010711A (es) Compuestos y composiciones novedosos como inhibidores de proteina-quinasa.
GEP20094845B (en) Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors
ATE430747T1 (de) 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren
ATE554087T1 (de) Neue kinaseinhibitoren
AU3113902A (en) Thiazolyl inhibitors of tec family tyrosine kinases
MX2009004714A (es) Derivados de pirazol fusionado 3-aminocarbonilo sustituidos como moduladores de proteina cinasa.
MXPA05012596A (es) Inhibidores de quinasa, de indazol, bencisoxazol y bencisotiazol.
CL2004000778A1 (es) Compuestos derivados de heterociclos de 5 miembros, inhibidores de la porteina tirosina fosfatasa 1b (ptp1b); composiciones farmaceuticas, utiles para tratar hipertension, obesidad, diabetes, hiperlipidemia.
EA200801291A1 (ru) Карбониламинопирролопиразолы в качестве эффективных ингибиторов киназ
UA91007C2 (ru) Замещенные 6-циклогексилалкилом замещенные 2-хинолиноны и 2-хиноксалиноны как ингибиторы поли-(адф-рибоза)полимеразы
MY143466A (en) Inhibitors of tyrosine kinases
NO20071915L (no) Diaminotriazolforbindelser nyttige som proteinkinaseinhibitorer
SV2005002148A (es) "compuestos moduladores de la actividad c-kit y usos de los mismos"
TW200801008A (en) Protein kinase inhibitors
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
EA200700848A1 (ru) Ингибиторы pi3-гамма-киназы для лечения анемии
MX2009004771A (es) Compuestos heteroaril triciclicos utiles como inhibidores de janus cinasa.
GB0121490D0 (en) Ciompounds
WO2003051838A3 (en) Protein kinase inhibitors
GB0308201D0 (en) Novel compounds
GB0121494D0 (en) Compounds
MX2009011576A (es) Nuevos derivados de 4,8-difenil-poliazanaftaleno.
WO2007066200A3 (en) Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120723